drugset / Trial / NCT02454478
Study of Lenvatinib in Combination With Everolimus in Participants With Unresectable Advanced or Metastatic Renal Cell Carcinoma (RCC)
NaSingle-groupOpen-labelTreatment
Summary
Phase 1 study to investigate the tolerability and safety of lenvatinib in combination with Everolimus in participants with unresectable advanced or metastatic RCC.
Timeline
- Start
- 2015-07-01
- Primary completion
- 2017-05-29
- Completion
- 2017-05-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lenvatinib | Small molecule | — | — |
| Background | Everolimus | Small molecule | — | — |